# A Study in Adults With Hereditary Angioedema (HAE) Who Currently Receive Icatibant at Home

> **NCT05489640** · — · COMPLETED · sponsor: **Takeda** · enrollment: 85 (actual)

## Conditions studied

- Hereditary Angioedema (HAE)

## Interventions

- **OTHER:** No Intervention

## Key facts

- **NCT ID:** NCT05489640
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-11-18
- **Primary completion:** 2024-07-17
- **Final completion:** 2024-07-17
- **Target enrollment:** 85 (ACTUAL)
- **Last updated:** 2024-08-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05489640

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05489640, "A Study in Adults With Hereditary Angioedema (HAE) Who Currently Receive Icatibant at Home". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05489640. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*